FATE Competitors & Alternatives
Compare Fate Therapeutics Inc with similar stocks in the same industry
Biotechnology
FATE
Main Stock$2.31
Tradestie Score
45
Market Cap
$144.16M
Revenue Growth
0.1%
Analyst Upside
+148.7%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.55
|
$304.12M | - | 49 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$17.89
|
$297.23M | - | 49 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.05
|
$293.03M | - | 57 | Compare |
|
OMER
Omeros Corporation
|
$18.28
|
$281.75M | 11.8 | 41 | Compare |
|
DBVT
DBV Technologies S.A.
|
$11.85
|
$275.54M | - | 38 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.78
|
$275.13M | - | 46 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$22.30
|
$269.08M | 0.1 | 47 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.21
|
$262.67M | - | 48 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$35.48
|
$256.54M | - | 43 | Compare |
More FATE Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry